Playback speed
10 seconds
AAO 2024 Insights: Safety and Efficacy of OCU400 Gene Modifier Therapy for Retinitis Pigmentosa - Phase 1/2 Study Updates
By
AAO 2024 Insights
FEATURING
Byron Lam
By
AAO 2024 Insights
FEATURING
Byron Lam
176 views
October 25, 2024
Comments 0
Login to view comments.
Click here to Login